Cost-Effectiveness of Using Brentuximab Vedotin in Patients with Recurrent Hodgkin Lymphoma or Refractory to Transplant
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2214
https://www.valueinhealthjournal.com/article/S1098-3015(16)33580-X/fulltext
Title :
Cost-Effectiveness of Using Brentuximab Vedotin in Patients with Recurrent Hodgkin Lymphoma or Refractory to Transplant
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33580-X&doi=10.1016/j.jval.2016.09.2214
First page :
A733
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2100